Resistance to conventional chemotherapy remains a major obstacle in the treatment of lung cancer and is largely driven by cancer stem-like cells (CSCs). Here, we investigated the molecular mechanisms underlying the anticancer activity of a hydroxylated chalcone derivative (UR-2) using CD133+ lung cancer organoid and xenograft models. Quantitative proteomic profiling identified mitochondrial Thioredoxin-2 (TRX2), encoded by the TXN2 gene, as a key regulator of UR-2-induced redox signaling.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Seo
Contact Seo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack